BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Cerenis Therapeutics, Inc. 

900 Victors Way
Suite 280
Ann Arbor  Michigan  48108  U.S.A.
Phone: 734-769-1110 Fax: 734-769-1132


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Cerenis Therapeutics, Inc.'s Cholesterol Drug CER-001 Fails In Mid-Stage Trial 1/2/2014 6:57:02 AM    More...
Cerenis Therapeutics, Inc. Selected as a 2012 Red Herring Top 100 Europe 4/27/2012 11:47:41 AM    More...
The Board of Cerenis Therapeutics, Inc. Appoints Dr. Richard C. Pasternak as Non Executive Director 11/22/2011 10:47:23 AM    More...
Cerenis Therapeutics, Inc. Appoints John F. Paolini as Chief Medical Officer 11/22/2011 8:44:03 AM    More...
Drug Veterans Court French Upstart, Cerenis Therapeutics, Inc. With Plaque Attack Remedy 4/8/2011 6:35:16 AM    More...
Cerenis Therapeutics, Inc. Initiates Phase 2 Study of Lead Product Candidate, CER-001, in Patients with Acute Coronary Syndrome 3/15/2011 10:37:20 AM    More...
Cerenis Therapeutics, Inc. Initiates Phase 2 Study of Lead Product Candidate, CER-001, in Patients with Acute Coronary Syndrome 3/15/2011 9:13:47 AM    More...
Cerenis Therapeutics, Inc. Adds To Stockpile With Another $13.9 Million 10/21/2010 6:37:50 AM    More...
Cerenis Therapeutics, Inc. And Novasep Awarded €10.7 Million Funding From The French Government For The Development CER-001, An HDL Mimetic 7/26/2010 11:17:31 AM    More...
Cerenis Therapeutics, Inc. Raises $51.7 Million in Series C Financing and Wins $13.8 Million from French Government 7/26/2010 6:42:33 AM    More...
123

//-->